HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max ...Middle East

SHANGHAI and REDWOOD CITY, Calif. , May 29, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corporation ("Synthego"), a leading provider of innovative CRISPR...

Hence then, the article about huidagene and synthego announce licensing agreement on next generation gene editing enzyme hfcas12max was published today ( Wednesday 29/05/2024 - 02:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max )

Also on site :

• Coda and Unity to enable out-of-app monetization for game developers globally
• Zoomlion fördert die intelligente Fertigung mit integrierter KI und Robotik mit eingebauter Intelligenz
• MOVA Launches Cleaning Solutions in Silicon Valley: Finding Answers for Premium Cleaning Through Pragmatic Innovation